India’s Drug Regulatory Apparatus Set For ‘Big Ticket’ Changes

Also Looks Inward To Improve

 
• By Anju Ghangurde
L-R: Nilesh Gupta, Managing Director, Lupin; Dr Rajeev Raghuvanshi, Drugs Controller General of India and Dr Arunish Chawla, Secretary, Department of Pharmaceuticals • Source: IPA

More from India

More from Asia